Download PDF
Facial Plast Surg 2019; 35(05): 549-558
DOI: 10.1055/s-0039-1697030
Original Research
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Are Cosmetic Procedures Comparable to Antidepressive Medication for Quality-of-Life Improvements? A Systematic Review and Controlled Meta-Analysis

Christina Rudolph
1   Division of Anatomy, Department of Medical Education, Albany Medical College, Albany, New York
,
Casey Hladik
1   Division of Anatomy, Department of Medical Education, Albany Medical College, Albany, New York
,
Donna F. Stroup
2   Data for Solutions, Inc.—Data for Solutions, Inc., Decatur, Georgia
,
Konstantin Frank
3   Department for Hand, Plastic and Aesthetic Surgery, Ludwig–Maximilian University, Munich, Germany
,
Robert H. Gotkin
4   Private Practice, New York City, New York
,
Steven H. Dayan
5   DeNova Research, Chicago, Illinois
,
Ashit Patel
6   Division of Plastic Surgery, Department of Surgery, Albany Medical Center, Albany, New York
,
Sebastian Cotofana
1   Division of Anatomy, Department of Medical Education, Albany Medical College, Albany, New York
6   Division of Plastic Surgery, Department of Surgery, Albany Medical Center, Albany, New York
› Author Affiliations
Funding The statistical analyses were funded by Merz North America, Inc., Raleigh, NC, USA (Grant No.:001-2018-1).
Further Information

Publication History

Publication Date:
28 September 2019 (online)

Also available at
   Permissions and Reprints

Abstract

Cosmetic procedures, especially cosmetic minimally invasive treatments, are rising in popularity, despite societal perception that these procedures may not improve patient health. The purpose of this study was to conduct a systematic review and controlled meta-analysis to compare the effects of cosmetic procedures and antidepressant treatment on health-related quality-of-life improvement. The PubMed database was queried in two independent searches to identify peer-reviewed cosmetic and antidepressant articles published between 1996 and 2017 that prospectively assessed the impact of the treatment on quality of life. All results were screened using defined exclusion and inclusion criteria and data were extracted using a standardized protocol. The meta-analysis was performed using a random-effects model. Five of 2,788 cosmetic studies and eight of 2,312 antidepressant studies met all inclusion criteria and utilized the 36-Item Short Form Health Survey (SF-36) measure. Except for the physical functioning scale, when compared with the cosmetic studies, antidepressant studies had significantly lower median baseline and post-treatment follow-up scale scores with larger median score improvement (p < 0.05). Positive effect sizes following treatment were observed for all eight SF-36 scales (range: 0.32–1.16; p < 0.05). This meta-analysis provides evidence that cosmetic procedures objectively improve a patient's health-related quality of life. While antidepressant studies exhibited greater SF-36 score improvement except for the physical functioning scale, both treatment groups demonstrated the greatest improvement in mental health and role emotional scales. As previously suggested, a disconnect exists between score improvement and clinical improvement due to baseline severity, ceiling effect, and regression to the mean effects.

Keywords

quality of life - aesthetic surgery - cosmetic surgery - antidepressant therapy - SF-36
 

  • References

  • 1 World Health Organization. Constitution of the World Health Organization. In: Basic Documents. 48th ed. Geneva, Switzerland: World Health Organization; 2014: 1-20
    Search in Google Scholar
  • 2 American Society of Plastic Surgeons. 2018 National Plastic Surgery Statistics. 2018 . Available at: https://www.plasticsurgery.org/documents/News/Statistics/2018/plastic-surgery-statistics-report-2018.pdf . Published 2019. Accessed April 14, 2019
    PubMedSearch in Google Scholar
  • 3 Atiyeh BS, Rubeiz MT, Hayek SN. Aesthetic/cosmetic surgery and ethical challenges. Aesthetic Plast Surg 2008; 32 (06) 829-839 , discussion 840–841
    CrossrefPubMedSearch in Google Scholar
  • 4 Mousavi SR. The ethics of aesthetic surgery. J Cutan Aesthet Surg 2010; 3 (01) 38-40
    CrossrefPubMedSearch in Google Scholar
  • 5 World Health Organization. ICD-11: International Statistical Classification of Diseases and Related Health Problems. Geneva, Switzerland: World Health Organization; 2018
    Search in Google Scholar
  • 6 Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M. Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry 2004; 26 (01) 13-17
    CrossrefPubMedSearch in Google Scholar
  • 7 IsHak WW, Greenberg JM, Balayan K. , et al. Quality of life: the ultimate outcome measure of interventions in major depressive disorder. Harv Rev Psychiatry 2011; 19 (05) 229-239
    CrossrefPubMedSearch in Google Scholar
  • 8 Ware Jr JE. SF-36 health survey update. Spine 2000; 25 (24) 3130-3139
    CrossrefPubMedSearch in Google Scholar
  • 9 Ware J, Snow K, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center; 1993
    Search in Google Scholar
  • 10 Ware J, Kosinski M, Keller S. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: Health Assessment Lab, New England Medical Center; 1994
    Search in Google Scholar
  • 11 The American Medical Association. Policy Compendium, H-475.992, “Definition of ‘Cosmetic’ and ‘Reconstructive’ Surgery.” Chicago, IL: American Medical Association
    PubMed
  • 12 American Society of Plastic Surgeons. Plastic Surgeons: A Delineation of Qualifications for Clinical Privileges. Arlington Heights, IL: American Society of Plastic Surgeons; 2014
    PubMed
  • 13 Lin CH, Yen YC, Chen MC, Chen CC. Relief of depression and pain improves daily functioning and quality of life in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2013; 47: 93-98.
    CrossrefPubMedSearch in Google Scholar
  • 14 Peveler R, Kendrick T, Buxton M. , et al. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. Health Technol Assess 2005; 9 (16) 1-134 , iii
    PubMedSearch in Google Scholar
  • 15 Higgins JGreen S. , eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration; 2011. http://handbook.cochrane.or
    Search in Google Scholar
  • 16 Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. . The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa, Ontario: Ottawa Hospital Research Institute
    PubMed
  • 17 Hedges LV. Estimation of effect size from a series of independent experiments. Psychol Bull 1982; 92 (02) 490-499
    CrossrefPubMedSearch in Google Scholar
  • 18 Alves MC, Abla LE, Santos RdeA, Ferreira LM. Quality of life and self-esteem outcomes following rhytidoplasty. Ann Plast Surg 2005; 54 (05) 511-514 , discussion 515–516
    CrossrefPubMedSearch in Google Scholar
  • 19 Hosseinzadeh K, Hamadzadeh H, Khorasani M, Jamshidi M. Health-related quality of life of persons after rhinoplasty: a longitudinal study among Iranian population. J Clin Diagn Res 2017; 11 (03) ZC60-ZC62
    PubMedSearch in Google Scholar
  • 20 Klassen A, Jenkinson C, Fitzpatrick R, Goodacre T. Patients' health related quality of life before and after aesthetic surgery. Br J Plast Surg 1996; 49 (07) 433-438
    CrossrefPubMedSearch in Google Scholar
  • 21 Murphy DK, Beckstrand M, Sarwer DBA. A prospective, multi-center study of psychosocial outcomes after augmentation with Natrelle silicone-filled breast implants. Ann Plast Surg 2009; 62 (02) 118-121
    CrossrefPubMedSearch in Google Scholar
  • 22 Tepavcevic B, Radak D, Jovanovic M, Radak S, Tepavcevic DK. The impact of facial lipofilling on patient-perceived improvement in facial appearance and quality of life. Facial Plast Surg 2016; 32 (03) 296-303
    Thieme ConnectPubMedSearch in Google Scholar
  • 23 Cao Y, Li W, Shen J, Malison RT, Zhang Y, Luo X. Health-related quality of life and symptom severity in Chinese patients with major depressive disorder. Asia-Pac Psychiatry 2013; 5 (04) 276-283
    PubMedSearch in Google Scholar
  • 24 Chokka P, Legault M. Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial. Depress Anxiety 2008; 25 (12) E173-E181
    CrossrefPubMedSearch in Google Scholar
  • 25 Hung CI, Wang SJ, Liu CY. Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder. Depress Anxiety 2009; 26 (06) 583-591
    CrossrefPubMedSearch in Google Scholar
  • 26 Kroenke K, West SL, Swindle R. , et al. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA 2001; 286 (23) 2947-2955
    CrossrefPubMedSearch in Google Scholar
  • 27 Simon GE, Revicki DA, Grothaus L, Vonkorff M. SF-36 summary scores: are physical and mental health truly distinct?. Med Care 1998; 36 (04) 567-572
    CrossrefPubMedSearch in Google Scholar
  • 28 Yang WC, Lin CH, Wang FC, Lu MJ. Factors related to the improvement in quality of life for depressed inpatients treated with fluoxetine. BMC Psychiatry 2017; 17 (01) 309
    CrossrefPubMedSearch in Google Scholar
  • 29 Sung SC, Wisniewski SR, Balasubramani GK. , et al; CO-MED Study Team. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report. Psychol Med 2013; 43 (05) 945-960
    CrossrefPubMedSearch in Google Scholar
  • 30 Yates WR, Mitchell J, Rush AJ. , et al. Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D. Gen Hosp Psychiatry 2004; 26 (06) 421-429
    CrossrefPubMedSearch in Google Scholar
  • 31 Cook SA, Rosser R, Salmon P. Is cosmetic surgery an effective psychotherapeutic intervention? A systematic review of the evidence. J Plast Reconstr Aesthet Surg 2006; 59 (11) 1133-1151
    CrossrefPubMedSearch in Google Scholar
  • 32 Dreher R, Blaya C, Tenório JLC, Saltz R, Ely PB, Ferrão YA. Quality of life and aesthetic plastic surgery: a systematic review and meta-analysis. Plast Reconstr Surg Glob Open 2016; 4 (09) e862
    CrossrefPubMedSearch in Google Scholar
  • 33 Imadojemu S, Sarwer DB, Percec I. , et al. Influence of surgical and minimally invasive facial cosmetic procedures on psychosocial outcomes: a systematic review. JAMA Dermatol 2013; 149 (11) 1325-1333
    CrossrefPubMedSearch in Google Scholar
  • 34 De Fruyt J, Demyttenaere K. Quality of life measurement in antidepressant trials. Is there an added value?. Psychother Psychosom 2009; 78 (04) 212-219
    CrossrefPubMedSearch in Google Scholar
  • 35 Spratt KF. Patient-level minimal clinically important difference based on clinical judgment and minimally detectable measurement difference: a rationale for the SF-36 physical function scale in the SPORT intervertebral disc herniation cohort. Spine 2009; 34 (16) 1722-1731
    CrossrefPubMedSearch in Google Scholar
  • 36 Stucki G, Daltroy L, Katz JN, Johannesson M, Liang MH. Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts. J Clin Epidemiol 1996; 49 (07) 711-717
    CrossrefPubMedSearch in Google Scholar
  • 37 Busija L, Osborne RH, Nilsdotter A, Buchbinder R, Roos EM. Health and Quality of Life Outcomes Magnitude and meaningfulness of change in SF-36 scores in four types of orthopedic surgery. Health Qual Life Outcomes 2008; 6: 55
    CrossrefPubMedSearch in Google Scholar
  • 38 Ward MM, Guthrie LC, Alba MI. Clinically important changes in Short Form 36 Health Survey scales for use in rheumatoid arthritis clinical trials: the impact of low responsiveness. Arthritis Care Res (Hoboken) 2014; 66 (12) 1783-1789
    CrossrefPubMedSearch in Google Scholar
  • 39 Bjorner JB, Lyng Wolden M, Gundgaard J, Miller KA. Benchmarks for interpretation of score differences on the SF-36 health survey for patients with diabetes. Value Health 2013; 16 (06) 993-1000
    CrossrefPubMedSearch in Google Scholar
  • 40 Baker DW, Hays RD, Brook RH. Understanding changes in health status. Is the floor phenomenon merely the last step of the staircase?. Med Care 1997; 35 (01) 1-15
    CrossrefPubMedSearch in Google Scholar
  • 41 Hemingway H, Stafford M, Stansfeld S, Shipley M, Marmot M. Is the SF-36 a valid measure of change in population health? Results from the Whitehall II Study. BMJ 1997; 315 (7118): 1273-1279
    CrossrefPubMedSearch in Google Scholar
  • 42 Lier HØ, Biringer E, Hove O, Stubhaug B, Tangen T. Quality of life among patients undergoing bariatric surgery: associations with mental health—a 1 year follow-up study of bariatric surgery patients. Health Qual Life Outcomes 2011; 9: 79-89
    CrossrefPubMedSearch in Google Scholar
  • 43 Ware JE, Snow KK, Kosinski M, Grandek B. SF-36 Health Survey: Manual and Interpretation Guide. Lincoln, RI: Quality Metric Inc; 2000
    Search in Google Scholar
  • 44 Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999; 15 (02) 141-155
    CrossrefPubMedSearch in Google Scholar